European Guarantee Services bids $42M for Cavitation Technologies and its Alchemy stake
What's the deal? Cavitation Technologies (CVAT)Dealroom has a profile for this one. Try Dealroom → on August 14, 2026, signed a definitive tender offer agreement with Luxembourg-based European Guarantee Services S.à.r.l. (EGS), which will seek to buy all outstanding CVAT common shares for $35 million in cash, net of certain debts and liabilities. The all-cash offer does not require prior shareholder approval.
The structure: EGS is expected to sign a separate tender offer to acquire all shares of Alchemy BeveragesDealroom has a profile for this one. Try Dealroom →, in which CVAT holds about 17% of the common stock, for $7 million in cash. That brings total consideration for the combined deals to $42 million.
Who's the target? CVAT, traded on the OTCQB, designs and makes nanotechnology systems for industrial and environmental uses. Its patent-backed technologies are deployed in water treatment, renewable fuels, and digital asset infrastructure. The company's current market cap is $11.46 million.
What's the endgame? The deal offers CVAT shareholders an exit and monetises its strategic stake in Alchemy. The agreements, announced August 17, 2026, mark a potential change of control.
What could go wrong? The offer carries several conditions: a minimum 90% share tender threshold, regulatory clearance including a Committee on Foreign Investment in the United States (CFIUS) review, and the accuracy of company representations. Failure to meet any could unwind the transaction.
The signal: A Luxembourg buyer taking a US nanotechnology firm private — subject to CFIUS scrutiny — reflects how cross-border acquisitions of small-cap technology assets now hinge as much on regulatory clearance as on price.
Read more: TipRanks
Image credit: jurvetson
